Global Parkinson’s Disease Drug Market to Grow at a CAGR of 3.58% During 2026-2035, Driven by Improving Healthcare Facilities

Drugs for Parkinson’s disease are expected to witness greater sales across the world as healthcare facilities across the world are improving both in terms of quality and reach. Since Parkinson’s disease is a neurogenerative disorder which affects motor capability especially amongst the elderly, a rise in ageing population has led to an increase in the incidences of Parkinson’s disease. Due to inadequate resources, the diagnosis of Parkinson’s disease may not be done properly, which has been changing in the historical period 2019-2025, because of more countries investing in research and healthcare facilities. With the rise in the number of smaller medical facilities and complementary facilities like diagnostic laboratories, as well as improving healthcare networks across the world, especially in developing countries, it has become easier to diagnose Parkinson’s disease at earlier stages. Europe has been leading the market, followed by America, owing to their robust healthcare networks and their complementary infrastructure of research and pharmaceutical companies. The rate of growth is expected to be high in Asia Pacific, especially Japan and China, with an increasing population rate and improving medical facilities.

Pfizer Inc (NYSE: PFE) is an American multinational pharmaceutical company which is a major player in the Parkinson’s disease drugs market. In 2018, Pfizer launched a new company, with investments from Bain Capital, aimed at drugs for Parkinson’s disease. As such, the value and growth rate for this market is expected to be high in the forecast period.

Market Analysis by Drug Class, Route of Administration, Distribution Channel, End-Use and Region:

• The market on the basis of drug class can be divided into MAO-B inhibitors, Levodopa, COMT inhibitors, dopamine agonists, and anticholinergics, amongst others.
• Based on route of administration, the industry can be divided into oral, injection and transdermal.
• The distribution channels for Parkinson’s disease drugs include hospital pharmacies, retail pharmacies, and online, amongst others.
• The end-use for Parkinson’s disease drugs can be divided into hospitals and clinics, amongst others.
• The regional markets for Parkinson’s disease drugs include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Key Findings of the Report:

• The market for Parkinson’s disease drugs is expected to grow due to the growing network of healthcare facilities, especially across developing countries.
• Rising ageing populations is expected to increase the incidences of Parkinson’s disease, in turn positively impacting the market for drugs.
• The influx of generic drugs plays a greater role in the expansion of market to a wider consumer base. 
• Strong drug pipelines across different pharmaceutical companies are expected to bring newer drugs for Parkinson’s disease to the forefront.

Key Offerings of the Report:

• The EMR report gives an overview of the global Parkinson’s disease drug market for the periods (2019-2025) and (2026-2035).
• The report also offers the historical (2019-2025) and forecast (2026-2035) markets for the drug class, route of administration, distribution channel, end-use and region of Parkinson’s disease drugs.
• The report analyses the market dynamics, covering the key demand and price indicators in the market, along with an assessment of the SWOT and Porter’s Five Forces models.

Top Players

• Pfizer, Inc.
• Medtronic plc
• GlaxoSmithKline plc.
• AbbVie Inc.
• Novartis AG
• Others

The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.

About Us

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over a 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us

Expert Market Research
Website: www.expertmarketresearch.com
Email: [email protected]
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790